Stock Analysis on Net
Stock Analysis on Net

AmerisourceBergen Corp. (NYSE:ABC)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 2, 2023.

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

Try for free

AmerisourceBergen Corp. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

AmerisourceBergen Corp., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016
Net income (loss)
Depreciation, including amounts charged to cost of goods sold
Amortization, including amounts charged to interest expense
Provision (benefit) for credit losses
Provision (benefit) for deferred income taxes
Share-based compensation expense
LIFO expense (credit)
Impairment of assets, including goodwill
Gain on sale of businesses
Turkey highly inflationary impact
Gain on sale of an equity investment
Gain on remeasurement of equity investment
Impairment of non-customer note receivable
Loss on consolidation of equity investments
Loss on early retirement of debt
Other, net
Accounts receivable
Inventories
Income tax receivable
Prepaid expenses and other assets
Accounts payable
Accrued expenses
Long-term accrued litigation liability
Income taxes payable and other liabilities
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Capital expenditures
Cost of acquired companies, net of cash acquired
Cost of equity investments
Proceeds from sale of property and equipment
Proceeds from sale of businesses
Proceeds from sales of investment securities available-for-sale
Purchases of investment securities available-for-sale
Other, net
Net cash used in investing activities
Senior notes and loan borrowings
Senior notes and loan repayments
Borrowings under revolving and securitization credit facilities
Repayments under revolving and securitization credit facilities
Payment of premium on early retirement of debt
Purchases of common stock
Exercises of stock options
Cash dividends on common stock
Profarma retail equity offering
Employee tax withholdings related to restricted share vesting
Other, net
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Increase (decrease) in cash, cash equivalents, and restricted cash, including cash classified within assets held for sale
(Increase) decrease in cash classified within assets held for sale
Increase (decrease) in cash, cash equivalents, and restricted cash

Based on: 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-Q (reporting date: 2022-12-31), 10-K (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-Q (reporting date: 2021-12-31), 10-K (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-Q (reporting date: 2020-12-31), 10-K (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-Q (reporting date: 2019-12-31), 10-K (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-Q (reporting date: 2018-12-31), 10-K (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-Q (reporting date: 2017-12-31), 10-K (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-Q (reporting date: 2016-12-31).

Cash flow statement item Description The company
Net cash provided by (used in) operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. AmerisourceBergen Corp. net cash provided by (used in) operating activities decreased from Q1 2023 to Q2 2023 but then increased from Q2 2023 to Q3 2023 exceeding Q1 2023 level.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. AmerisourceBergen Corp. net cash used in investing activities increased from Q1 2023 to Q2 2023 but then slightly decreased from Q2 2023 to Q3 2023 not reaching Q1 2023 level.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. AmerisourceBergen Corp. net cash provided by (used in) financing activities increased from Q1 2023 to Q2 2023 and from Q2 2023 to Q3 2023.